| Literature DB >> 26572722 |
Joanna Thornley1, Hussein Hirjee2, Akshya Vasudev3.
Abstract
The prevalence of dementia continues to grow worldwide due to an aging population and is projected to affect 65.7 million people by 2030 (World Health Organization, 2012). Behavioral and psychological symptoms of dementia (BPSD), including agitation, anxiety, aggression, depression, and psychosis, can occur in as much as 80% of the affected population, frequently necessitating psychiatric admission. Traditionally BPSD have been treated using pharmacological approaches. However, such medications could have serious adverse effects and additionally have limited efficacy in reducing such symptoms (Ballard et al., 2009).Entities:
Mesh:
Year: 2015 PMID: 26572722 DOI: 10.1017/S1041610215001866
Source DB: PubMed Journal: Int Psychogeriatr ISSN: 1041-6102 Impact factor: 3.878